 | • レポートコード：MRC2-11QY14434 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は前立腺特異抗原のグローバル市場について調査・分析したレポートです。種類別（G-115、INO-5150、ADXS-PSA、AEZS-120、その他）市場規模、用途別（前立腺がん、転移性ホルモン不応性前立腺がん、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別前立腺特異抗原の競争状況、市場シェア ・世界の前立腺特異抗原市場：種類別市場規模 2015年-2020年（G-115、INO-5150、ADXS-PSA、AEZS-120、その他） ・世界の前立腺特異抗原市場：種類別市場規模予測 2021年-2026年（G-115、INO-5150、ADXS-PSA、AEZS-120、その他） ・世界の前立腺特異抗原市場：用途別市場規模 2015年-2020年（前立腺がん、転移性ホルモン不応性前立腺がん、その他） ・世界の前立腺特異抗原市場：用途別市場規模予測 2021年-2026年（前立腺がん、転移性ホルモン不応性前立腺がん、その他） ・北米の前立腺特異抗原市場分析：米国、カナダ ・ヨーロッパの前立腺特異抗原市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの前立腺特異抗原市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の前立腺特異抗原市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの前立腺特異抗原市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Advaxis, Inc.、Aeterna Zentaris Inc.、Bavarian Nordic A/S、Curevac AG、GenSpera, Inc.、Inovio Pharmaceuticals, Inc.、OncBioMune Pharmaceuticals Inc. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Prostate Specific Antigen Market
The global Prostate Specific Antigen market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Prostate Specific Antigen Scope and Market Size
Prostate Specific Antigen market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Prostate Specific Antigen market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Prostate Specific Antigen market is segmented into
G-115
INO-5150
ADXS-PSA
AEZS-120
Others
Segment by Application, the Prostate Specific Antigen market is segmented into
Prostate Cancer
Metastatic Hormone Refractory Prostate Cancer
Others
Regional and Country-level Analysis
The Prostate Specific Antigen market is analysed and market size information is provided by regions (countries).
The key regions covered in the Prostate Specific Antigen market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Prostate Specific Antigen Market Share Analysis
Prostate Specific Antigen market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Prostate Specific Antigen business, the date to enter into the Prostate Specific Antigen market, Prostate Specific Antigen product introduction, recent developments, etc.
The major vendors covered:
Advaxis, Inc.
Aeterna Zentaris Inc.
Bavarian Nordic A/S
Curevac AG
GenSpera, Inc.
Inovio Pharmaceuticals, Inc.
OncBioMune Pharmaceuticals Inc.
…
1 Study Coverage
1.1 Prostate Specific Antigen Product Introduction
1.2 Market Segments
1.3 Key Prostate Specific Antigen Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Prostate Specific Antigen Market Size Growth Rate by Type
1.4.2 G-115
1.4.3 INO-5150
1.4.4 ADXS-PSA
1.4.5 AEZS-120
1.4.6 Others
1.5 Market by Application
1.5.1 Global Prostate Specific Antigen Market Size Growth Rate by Application
1.5.2 Prostate Cancer
1.5.3 Metastatic Hormone Refractory Prostate Cancer
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Prostate Specific Antigen Market Size, Estimates and Forecasts
2.1.1 Global Prostate Specific Antigen Revenue 2015-2026
2.1.2 Global Prostate Specific Antigen Sales 2015-2026
2.2 Global Prostate Specific Antigen, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Prostate Specific Antigen Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Prostate Specific Antigen Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Prostate Specific Antigen Competitor Landscape by Players
3.1 Prostate Specific Antigen Sales by Manufacturers
3.1.1 Prostate Specific Antigen Sales by Manufacturers (2015-2020)
3.1.2 Prostate Specific Antigen Sales Market Share by Manufacturers (2015-2020)
3.2 Prostate Specific Antigen Revenue by Manufacturers
3.2.1 Prostate Specific Antigen Revenue by Manufacturers (2015-2020)
3.2.2 Prostate Specific Antigen Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Prostate Specific Antigen Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Prostate Specific Antigen Revenue in 2019
3.2.5 Global Prostate Specific Antigen Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Prostate Specific Antigen Price by Manufacturers
3.4 Prostate Specific Antigen Manufacturing Base Distribution, Product Types
3.4.1 Prostate Specific Antigen Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Prostate Specific Antigen Product Type
3.4.3 Date of International Manufacturers Enter into Prostate Specific Antigen Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Prostate Specific Antigen Market Size by Type (2015-2020)
4.1.1 Global Prostate Specific Antigen Sales by Type (2015-2020)
4.1.2 Global Prostate Specific Antigen Revenue by Type (2015-2020)
4.1.3 Prostate Specific Antigen Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Prostate Specific Antigen Market Size Forecast by Type (2021-2026)
4.2.1 Global Prostate Specific Antigen Sales Forecast by Type (2021-2026)
4.2.2 Global Prostate Specific Antigen Revenue Forecast by Type (2021-2026)
4.2.3 Prostate Specific Antigen Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Prostate Specific Antigen Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Prostate Specific Antigen Market Size by Application (2015-2020)
5.1.1 Global Prostate Specific Antigen Sales by Application (2015-2020)
5.1.2 Global Prostate Specific Antigen Revenue by Application (2015-2020)
5.1.3 Prostate Specific Antigen Price by Application (2015-2020)
5.2 Prostate Specific Antigen Market Size Forecast by Application (2021-2026)
5.2.1 Global Prostate Specific Antigen Sales Forecast by Application (2021-2026)
5.2.2 Global Prostate Specific Antigen Revenue Forecast by Application (2021-2026)
5.2.3 Global Prostate Specific Antigen Price Forecast by Application (2021-2026)
6 North America
6.1 North America Prostate Specific Antigen by Country
6.1.1 North America Prostate Specific Antigen Sales by Country
6.1.2 North America Prostate Specific Antigen Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Prostate Specific Antigen Market Facts & Figures by Type
6.3 North America Prostate Specific Antigen Market Facts & Figures by Application
7 Europe
7.1 Europe Prostate Specific Antigen by Country
7.1.1 Europe Prostate Specific Antigen Sales by Country
7.1.2 Europe Prostate Specific Antigen Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Prostate Specific Antigen Market Facts & Figures by Type
7.3 Europe Prostate Specific Antigen Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Prostate Specific Antigen by Region
8.1.1 Asia Pacific Prostate Specific Antigen Sales by Region
8.1.2 Asia Pacific Prostate Specific Antigen Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Prostate Specific Antigen Market Facts & Figures by Type
8.3 Asia Pacific Prostate Specific Antigen Market Facts & Figures by Application
9 Latin America
9.1 Latin America Prostate Specific Antigen by Country
9.1.1 Latin America Prostate Specific Antigen Sales by Country
9.1.2 Latin America Prostate Specific Antigen Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Prostate Specific Antigen Market Facts & Figures by Type
9.3 Central & South America Prostate Specific Antigen Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Prostate Specific Antigen by Country
10.1.1 Middle East and Africa Prostate Specific Antigen Sales by Country
10.1.2 Middle East and Africa Prostate Specific Antigen Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Prostate Specific Antigen Market Facts & Figures by Type
10.3 Middle East and Africa Prostate Specific Antigen Market Facts & Figures by Application
11 Company Profiles
11.1 Advaxis, Inc.
11.1.1 Advaxis, Inc. Corporation Information
11.1.2 Advaxis, Inc. Description and Business Overview
11.1.3 Advaxis, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Advaxis, Inc. Prostate Specific Antigen Products Offered
11.1.5 Advaxis, Inc. Related Developments
11.2 Aeterna Zentaris Inc.
11.2.1 Aeterna Zentaris Inc. Corporation Information
11.2.2 Aeterna Zentaris Inc. Description and Business Overview
11.2.3 Aeterna Zentaris Inc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Aeterna Zentaris Inc. Prostate Specific Antigen Products Offered
11.2.5 Aeterna Zentaris Inc. Related Developments
11.3 Bavarian Nordic A/S
11.3.1 Bavarian Nordic A/S Corporation Information
11.3.2 Bavarian Nordic A/S Description and Business Overview
11.3.3 Bavarian Nordic A/S Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bavarian Nordic A/S Prostate Specific Antigen Products Offered
11.3.5 Bavarian Nordic A/S Related Developments
11.4 Curevac AG
11.4.1 Curevac AG Corporation Information
11.4.2 Curevac AG Description and Business Overview
11.4.3 Curevac AG Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Curevac AG Prostate Specific Antigen Products Offered
11.4.5 Curevac AG Related Developments
11.5 GenSpera, Inc.
11.5.1 GenSpera, Inc. Corporation Information
11.5.2 GenSpera, Inc. Description and Business Overview
11.5.3 GenSpera, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 GenSpera, Inc. Prostate Specific Antigen Products Offered
11.5.5 GenSpera, Inc. Related Developments
11.6 Inovio Pharmaceuticals, Inc.
11.6.1 Inovio Pharmaceuticals, Inc. Corporation Information
11.6.2 Inovio Pharmaceuticals, Inc. Description and Business Overview
11.6.3 Inovio Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Products Offered
11.6.5 Inovio Pharmaceuticals, Inc. Related Developments
11.7 OncBioMune Pharmaceuticals Inc.
11.7.1 OncBioMune Pharmaceuticals Inc. Corporation Information
11.7.2 OncBioMune Pharmaceuticals Inc. Description and Business Overview
11.7.3 OncBioMune Pharmaceuticals Inc. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Products Offered
11.7.5 OncBioMune Pharmaceuticals Inc. Related Developments
11.1 Advaxis, Inc.
11.1.1 Advaxis, Inc. Corporation Information
11.1.2 Advaxis, Inc. Description and Business Overview
11.1.3 Advaxis, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Advaxis, Inc. Prostate Specific Antigen Products Offered
11.1.5 Advaxis, Inc. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Prostate Specific Antigen Market Estimates and Projections by Region
12.1.1 Global Prostate Specific Antigen Sales Forecast by Regions 2021-2026
12.1.2 Global Prostate Specific Antigen Revenue Forecast by Regions 2021-2026
12.2 North America Prostate Specific Antigen Market Size Forecast (2021-2026)
12.2.1 North America: Prostate Specific Antigen Sales Forecast (2021-2026)
12.2.2 North America: Prostate Specific Antigen Revenue Forecast (2021-2026)
12.2.3 North America: Prostate Specific Antigen Market Size Forecast by Country (2021-2026)
12.3 Europe Prostate Specific Antigen Market Size Forecast (2021-2026)
12.3.1 Europe: Prostate Specific Antigen Sales Forecast (2021-2026)
12.3.2 Europe: Prostate Specific Antigen Revenue Forecast (2021-2026)
12.3.3 Europe: Prostate Specific Antigen Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Prostate Specific Antigen Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Prostate Specific Antigen Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Prostate Specific Antigen Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Prostate Specific Antigen Market Size Forecast by Region (2021-2026)
12.5 Latin America Prostate Specific Antigen Market Size Forecast (2021-2026)
12.5.1 Latin America: Prostate Specific Antigen Sales Forecast (2021-2026)
12.5.2 Latin America: Prostate Specific Antigen Revenue Forecast (2021-2026)
12.5.3 Latin America: Prostate Specific Antigen Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Prostate Specific Antigen Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Prostate Specific Antigen Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Prostate Specific Antigen Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Prostate Specific Antigen Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Prostate Specific Antigen Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Prostate Specific Antigen Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Prostate Specific Antigen Market Segments
Table 2. Ranking of Global Top Prostate Specific Antigen Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Prostate Specific Antigen Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of G-115
Table 5. Major Manufacturers of INO-5150
Table 6. Major Manufacturers of ADXS-PSA
Table 7. Major Manufacturers of AEZS-120
Table 8. Major Manufacturers of Others
Table 9. Global Prostate Specific Antigen Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Prostate Specific Antigen Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Prostate Specific Antigen Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Prostate Specific Antigen Sales Market Share by Regions (2015-2020)
Table 13. Global Prostate Specific Antigen Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Prostate Specific Antigen Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Prostate Specific Antigen Sales Share by Manufacturers (2015-2020)
Table 16. Global Prostate Specific Antigen Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Prostate Specific Antigen by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Specific Antigen as of 2019)
Table 18. Prostate Specific Antigen Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Prostate Specific Antigen Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Prostate Specific Antigen Price (2015-2020) (USD/Pcs)
Table 21. Prostate Specific Antigen Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Prostate Specific Antigen Product Type
Table 23. Date of International Manufacturers Enter into Prostate Specific Antigen Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Prostate Specific Antigen Sales by Type (2015-2020) (K Pcs)
Table 26. Global Prostate Specific Antigen Sales Share by Type (2015-2020)
Table 27. Global Prostate Specific Antigen Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Prostate Specific Antigen Revenue Share by Type (2015-2020)
Table 29. Prostate Specific Antigen Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Prostate Specific Antigen Sales by Application (2015-2020) (K Pcs)
Table 31. Global Prostate Specific Antigen Sales Share by Application (2015-2020)
Table 32. North America Prostate Specific Antigen Sales by Country (2015-2020) (K Pcs)
Table 33. North America Prostate Specific Antigen Sales Market Share by Country (2015-2020)
Table 34. North America Prostate Specific Antigen Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Prostate Specific Antigen Revenue Market Share by Country (2015-2020)
Table 36. North America Prostate Specific Antigen Sales by Type (2015-2020) (K Pcs)
Table 37. North America Prostate Specific Antigen Sales Market Share by Type (2015-2020)
Table 38. North America Prostate Specific Antigen Sales by Application (2015-2020) (K Pcs)
Table 39. North America Prostate Specific Antigen Sales Market Share by Application (2015-2020)
Table 40. Europe Prostate Specific Antigen Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Prostate Specific Antigen Sales Market Share by Country (2015-2020)
Table 42. Europe Prostate Specific Antigen Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Prostate Specific Antigen Revenue Market Share by Country (2015-2020)
Table 44. Europe Prostate Specific Antigen Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Prostate Specific Antigen Sales Market Share by Type (2015-2020)
Table 46. Europe Prostate Specific Antigen Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Prostate Specific Antigen Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Prostate Specific Antigen Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Prostate Specific Antigen Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Prostate Specific Antigen Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Prostate Specific Antigen Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Prostate Specific Antigen Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Prostate Specific Antigen Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Prostate Specific Antigen Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Prostate Specific Antigen Sales Market Share by Application (2015-2020)
Table 56. Latin America Prostate Specific Antigen Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Prostate Specific Antigen Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Prostate Specific Antigen Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Prostate Specific Antigen Revenue Market Share by Country (2015-2020)
Table 60. Latin America Prostate Specific Antigen Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Prostate Specific Antigen Sales Market Share by Type (2015-2020)
Table 62. Latin America Prostate Specific Antigen Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Prostate Specific Antigen Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Prostate Specific Antigen Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Prostate Specific Antigen Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Prostate Specific Antigen Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Prostate Specific Antigen Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Prostate Specific Antigen Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Prostate Specific Antigen Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Prostate Specific Antigen Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Prostate Specific Antigen Sales Market Share by Application (2015-2020)
Table 72. Advaxis, Inc. Corporation Information
Table 73. Advaxis, Inc. Description and Major Businesses
Table 74. Advaxis, Inc. Prostate Specific Antigen Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Advaxis, Inc. Product
Table 76. Advaxis, Inc. Recent Development
Table 77. Aeterna Zentaris Inc. Corporation Information
Table 78. Aeterna Zentaris Inc. Description and Major Businesses
Table 79. Aeterna Zentaris Inc. Prostate Specific Antigen Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Aeterna Zentaris Inc. Product
Table 81. Aeterna Zentaris Inc. Recent Development
Table 82. Bavarian Nordic A/S Corporation Information
Table 83. Bavarian Nordic A/S Description and Major Businesses
Table 84. Bavarian Nordic A/S Prostate Specific Antigen Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Bavarian Nordic A/S Product
Table 86. Bavarian Nordic A/S Recent Development
Table 87. Curevac AG Corporation Information
Table 88. Curevac AG Description and Major Businesses
Table 89. Curevac AG Prostate Specific Antigen Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Curevac AG Product
Table 91. Curevac AG Recent Development
Table 92. GenSpera, Inc. Corporation Information
Table 93. GenSpera, Inc. Description and Major Businesses
Table 94. GenSpera, Inc. Prostate Specific Antigen Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. GenSpera, Inc. Product
Table 96. GenSpera, Inc. Recent Development
Table 97. Inovio Pharmaceuticals, Inc. Corporation Information
Table 98. Inovio Pharmaceuticals, Inc. Description and Major Businesses
Table 99. Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Inovio Pharmaceuticals, Inc. Product
Table 101. Inovio Pharmaceuticals, Inc. Recent Development
Table 102. OncBioMune Pharmaceuticals Inc. Corporation Information
Table 103. OncBioMune Pharmaceuticals Inc. Description and Major Businesses
Table 104. OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. OncBioMune Pharmaceuticals Inc. Product
Table 106. OncBioMune Pharmaceuticals Inc. Recent Development
Table 107. Global Prostate Specific Antigen Sales Forecast by Regions (2021-2026) (K Pcs)
Table 108. Global Prostate Specific Antigen Sales Market Share Forecast by Regions (2021-2026)
Table 109. Global Prostate Specific Antigen Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 110. Global Prostate Specific Antigen Revenue Market Share Forecast by Regions (2021-2026)
Table 111. North America: Prostate Specific Antigen Sales Forecast by Country (2021-2026) (K Pcs)
Table 112. North America: Prostate Specific Antigen Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Europe: Prostate Specific Antigen Sales Forecast by Country (2021-2026) (K Pcs)
Table 114. Europe: Prostate Specific Antigen Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Asia Pacific: Prostate Specific Antigen Sales Forecast by Region (2021-2026) (K Pcs)
Table 116. Asia Pacific: Prostate Specific Antigen Revenue Forecast by Region (2021-2026) (US$ Million)
Table 117. Latin America: Prostate Specific Antigen Sales Forecast by Country (2021-2026) (K Pcs)
Table 118. Latin America: Prostate Specific Antigen Revenue Forecast by Country (2021-2026) (US$ Million)
Table 119. Middle East and Africa: Prostate Specific Antigen Sales Forecast by Country (2021-2026) (K Pcs)
Table 120. Middle East and Africa: Prostate Specific Antigen Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 122. Key Challenges
Table 123. Market Risks
Table 124. Main Points Interviewed from Key Prostate Specific Antigen Players
Table 125. Prostate Specific Antigen Customers List
Table 126. Prostate Specific Antigen Distributors List
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Prostate Specific Antigen Product Picture
Figure 2. Global Prostate Specific Antigen Sales Market Share by Type in 2020 & 2026
Figure 3. G-115 Product Picture
Figure 4. INO-5150 Product Picture
Figure 5. ADXS-PSA Product Picture
Figure 6. AEZS-120 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Prostate Specific Antigen Sales Market Share by Application in 2020 & 2026
Figure 9. Prostate Cancer
Figure 10. Metastatic Hormone Refractory Prostate Cancer
Figure 11. Others
Figure 12. Prostate Specific Antigen Report Years Considered
Figure 13. Global Prostate Specific Antigen Market Size 2015-2026 (US$ Million)
Figure 14. Global Prostate Specific Antigen Sales 2015-2026 (K Pcs)
Figure 15. Global Prostate Specific Antigen Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Prostate Specific Antigen Sales Market Share by Region (2015-2020)
Figure 17. Global Prostate Specific Antigen Sales Market Share by Region in 2019
Figure 18. Global Prostate Specific Antigen Revenue Market Share by Region (2015-2020)
Figure 19. Global Prostate Specific Antigen Revenue Market Share by Region in 2019
Figure 20. Global Prostate Specific Antigen Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Prostate Specific Antigen Revenue in 2019
Figure 22. Prostate Specific Antigen Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Prostate Specific Antigen Sales Market Share by Type (2015-2020)
Figure 24. Global Prostate Specific Antigen Sales Market Share by Type in 2019
Figure 25. Global Prostate Specific Antigen Revenue Market Share by Type (2015-2020)
Figure 26. Global Prostate Specific Antigen Revenue Market Share by Type in 2019
Figure 27. Global Prostate Specific Antigen Market Share by Price Range (2015-2020)
Figure 28. Global Prostate Specific Antigen Sales Market Share by Application (2015-2020)
Figure 29. Global Prostate Specific Antigen Sales Market Share by Application in 2019
Figure 30. Global Prostate Specific Antigen Revenue Market Share by Application (2015-2020)
Figure 31. Global Prostate Specific Antigen Revenue Market Share by Application in 2019
Figure 32. North America Prostate Specific Antigen Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Prostate Specific Antigen Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Prostate Specific Antigen Sales Market Share by Country in 2019
Figure 35. North America Prostate Specific Antigen Revenue Market Share by Country in 2019
Figure 36. U.S. Prostate Specific Antigen Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Prostate Specific Antigen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Prostate Specific Antigen Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Prostate Specific Antigen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Prostate Specific Antigen Market Share by Type in 2019
Figure 41. North America Prostate Specific Antigen Market Share by Application in 2019
Figure 42. Europe Prostate Specific Antigen Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Prostate Specific Antigen Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Prostate Specific Antigen Sales Market Share by Country in 2019
Figure 45. Europe Prostate Specific Antigen Revenue Market Share by Country in 2019
Figure 46. Germany Prostate Specific Antigen Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Prostate Specific Antigen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Prostate Specific Antigen Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Prostate Specific Antigen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Prostate Specific Antigen Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Prostate Specific Antigen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Prostate Specific Antigen Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Prostate Specific Antigen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Prostate Specific Antigen Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Prostate Specific Antigen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Prostate Specific Antigen Market Share by Type in 2019
Figure 57. Europe Prostate Specific Antigen Market Share by Application in 2019
Figure 58. Asia Pacific Prostate Specific Antigen Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Prostate Specific Antigen Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Prostate Specific Antigen Sales Market Share by Region in 2019
Figure 61. Asia Pacific Prostate Specific Antigen Revenue Market Share by Region in 2019
Figure 62. China Prostate Specific Antigen Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Prostate Specific Antigen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Prostate Specific Antigen Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Prostate Specific Antigen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Prostate Specific Antigen Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Prostate Specific Antigen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Prostate Specific Antigen Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Prostate Specific Antigen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Prostate Specific Antigen Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Prostate Specific Antigen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Prostate Specific Antigen Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Prostate Specific Antigen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Prostate Specific Antigen Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Prostate Specific Antigen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Prostate Specific Antigen Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Prostate Specific Antigen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Prostate Specific Antigen Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Prostate Specific Antigen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Prostate Specific Antigen Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Prostate Specific Antigen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Prostate Specific Antigen Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Prostate Specific Antigen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Prostate Specific Antigen Market Share by Type in 2019
Figure 85. Asia Pacific Prostate Specific Antigen Market Share by Application in 2019
Figure 86. Latin America Prostate Specific Antigen Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Prostate Specific Antigen Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Prostate Specific Antigen Sales Market Share by Country in 2019
Figure 89. Latin America Prostate Specific Antigen Revenue Market Share by Country in 2019
Figure 90. Mexico Prostate Specific Antigen Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Prostate Specific Antigen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Prostate Specific Antigen Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Prostate Specific Antigen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Prostate Specific Antigen Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Prostate Specific Antigen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Prostate Specific Antigen Market Share by Type in 2019
Figure 97. Latin America Prostate Specific Antigen Market Share by Application in 2019
Figure 98. Middle East and Africa Prostate Specific Antigen Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Prostate Specific Antigen Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Prostate Specific Antigen Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Prostate Specific Antigen Revenue Market Share by Country in 2019
Figure 102. Turkey Prostate Specific Antigen Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Prostate Specific Antigen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Prostate Specific Antigen Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Prostate Specific Antigen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Prostate Specific Antigen Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Prostate Specific Antigen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Prostate Specific Antigen Market Share by Type in 2019
Figure 109. Middle East and Africa Prostate Specific Antigen Market Share by Application in 2019
Figure 110. North America Prostate Specific Antigen Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Prostate Specific Antigen Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Prostate Specific Antigen Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Prostate Specific Antigen Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Prostate Specific Antigen Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Prostate Specific Antigen Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Prostate Specific Antigen Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Prostate Specific Antigen Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Prostate Specific Antigen Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Prostate Specific Antigen Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
ホルモン抵抗性前立腺がんの世界市場（～2026年） Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, …- 前立腺がんの世界市場（～2026年） Prostate cancer is cancer that occurs in the prostate. Market Analysis and Insights: Global Prostate Cancer Market The global Prostate Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Prostate Cancer Scope and Ma…
- 前立腺がん診断・治療の世界市場（～2026年） Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. The market is growing impressively due to rise in incidence and prevalence rate of prostate cancer, robust R&D exploration and rising investment in grants and investment across the globe. Market An…
- 前立腺がん治療の世界市場（～2026年） Prostate cancer is the most common cancer among men, the key risk factors for prostate cancer development is being old age, genetic, obesity and race. Market Analysis and Insights: Global Prostate Cancer Treatment Market The global Prostate Cancer Treatment market size is projected to reach US$ XX m…
- 前立腺がんバイオマーカーの世界市場（～2026年） Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. The prostate cancer biomarker market is expected to witness a fast growth owing to rising prevalence of prostate cancer. Market Analysis and Insights: Global Prostate Cancer Biomarker Market The gl…